• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 与医院管理成本:意大利的经验。

COVID-19 and hospital management costs: the Italian experience.

机构信息

Healthcare Datascience Lab (HD LAB), Centre for Health Economics, Social and Health Care Management, Carlo Cattaneo - LIUC University, 21053, Castellanza, Italy.

出版信息

BMC Health Serv Res. 2022 Aug 4;22(1):991. doi: 10.1186/s12913-022-08365-9.

DOI:10.1186/s12913-022-08365-9
PMID:35922849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9351199/
Abstract

BACKGROUND

This article investigates the hospital costs related to the management of COVID-19 positive patients, requiring a hospitalization (from the positivity confirmation to discharge, including rehabilitation activities).

METHODS

A time-driven activity-based costing analysis, grounding on administrative and accounting flows provided by the management control, was implemented to define costs related to the hospital management of COVID-19 positive patients, according to real-word data, derived from six public Italian Hospitals, in 2020.

RESULTS

Results reported that the higher the complexity of care, the higher the hospitalization cost per day (low-complexity = €475.86; medium-complexity = €700.20; high-complexity = €1,401.65). Focusing on the entire clinical pathway, the overall resources absorption, with the inclusion of rehabilitation costs, ranged from 6,198.02€ to 32,141.20€, dependent from the patient's clinical condition.

CONCLUSIONS

Data could represent the baseline cost for COVID-19 hospital management, thus being useful for the further development of proper reimbursement tariffs devoted to hospitalized infected patients.

摘要

背景

本文研究了与管理 COVID-19 阳性患者相关的医院成本,这些患者需要住院治疗(从阳性确诊到出院,包括康复活动)。

方法

根据管理控制提供的行政和会计流程,采用时间驱动的作业成本分析方法,根据 2020 年六家意大利公立医院的实际数据,确定与 COVID-19 阳性患者的医院管理相关的成本。

结果

结果表明,护理复杂性越高,每天的住院费用越高(低复杂性=475.86 欧元;中复杂性=700.20 欧元;高复杂性=1401.65 欧元)。从整个临床路径来看,包括康复费用在内的整体资源消耗从 6198.02 欧元到 32141.20 欧元不等,取决于患者的临床状况。

结论

数据可以代表 COVID-19 医院管理的基准成本,因此对于制定专门用于感染住院患者的适当报销费率非常有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/b3eac060afed/12913_2022_8365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/dae2a4602c43/12913_2022_8365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/594404ec1ddd/12913_2022_8365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/213a0f26dfd4/12913_2022_8365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/b3eac060afed/12913_2022_8365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/dae2a4602c43/12913_2022_8365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/594404ec1ddd/12913_2022_8365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/213a0f26dfd4/12913_2022_8365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c2/9351199/b3eac060afed/12913_2022_8365_Fig4_HTML.jpg

相似文献

1
COVID-19 and hospital management costs: the Italian experience.COVID-19 与医院管理成本:意大利的经验。
BMC Health Serv Res. 2022 Aug 4;22(1):991. doi: 10.1186/s12913-022-08365-9.
2
Comparison of COVID-19 hospitalization costs across care pathways: a patient-level time-driven activity-based costing analysis in a Brazilian hospital.比较不同护理路径下 COVID-19 住院费用:巴西一家医院基于患者水平的时间驱动作业成本分析。
BMC Health Serv Res. 2023 Feb 24;23(1):198. doi: 10.1186/s12913-023-09049-8.
3
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy.意大利医院和社会保障体系视角下的精神分裂症经济影响。
Clin Drug Investig. 2021 Feb;41(2):183-191. doi: 10.1007/s40261-020-00991-7. Epub 2021 Feb 9.
4
Cost Analysis of Hospitalization for COVID-19 in a Brazilian Public Teaching Hospital.巴西公立教学医院 COVID-19 住院费用分析。
Value Health Reg Issues. 2023 Mar;34:48-54. doi: 10.1016/j.vhri.2022.10.006. Epub 2022 Dec 2.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Costs of children with medical complexity in Australian public hospitals.澳大利亚公立医院中患有复杂疾病儿童的费用。
J Paediatr Child Health. 2016 May;52(5):566-71. doi: 10.1111/jpc.13152.
7
Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals.COVID-19 患者在巴西三家公立医院的住院费用。
Value Health Reg Issues. 2023 Jul;36:34-43. doi: 10.1016/j.vhri.2023.02.004. Epub 2023 Apr 3.
8
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors.COVID-19 相关的医院成本-结果分析:临床和人口统计学因素的影响。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101609. doi: 10.1016/j.bjid.2021.101609. Epub 2021 Aug 19.
9
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.1型或2型糖尿病患者血糖控制与糖尿病相关住院费用之间的关系。
J Manag Care Pharm. 2010 May;16(4):264-75. doi: 10.18553/jmcp.2010.16.4.264.
10
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.

引用本文的文献

1
[Not Available].[无可用内容]
Glob Reg Health Technol Assess. 2025 Jul 17;12:168-176. doi: 10.33393/grhta.2025.3403. eCollection 2025 Jan-Dec.
2
Facility Management Costs for Hospital Infrastructures: Insights from the Italian Healthcare System.医院基础设施的设施管理成本:来自意大利医疗保健系统的见解
Healthcare (Basel). 2025 Apr 17;13(8):924. doi: 10.3390/healthcare13080924.
3
Measuring productivity in the healthcare sector: a bibliometric and content analysis.衡量医疗保健部门的生产率:文献计量与内容分析

本文引用的文献

1
Indirect impact of Covid-19 on hospital care pathways in Italy.意大利新冠疫情对医院护理路径的间接影响。
Sci Rep. 2021 Nov 2;11(1):21526. doi: 10.1038/s41598-021-00982-4.
2
Epidemiological and economic impact of COVID-19 in the US.新冠疫情对美国的流行病学和经济影响。
Sci Rep. 2021 Oct 14;11(1):20451. doi: 10.1038/s41598-021-99712-z.
3
COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic.土耳其新冠疫情医疗成本及住院时长:大流行首个高峰期的回顾性分析
Health Econ Rev. 2025 Mar 18;15(1):24. doi: 10.1186/s13561-025-00612-z.
4
Renal Replacement Therapy in Methylmalonic Aciduria-Related Metabolic Failure: Case Report and Literature Review.甲基丙二酸血症相关代谢衰竭的肾脏替代治疗:病例报告及文献综述
J Clin Med. 2024 Jul 23;13(15):4304. doi: 10.3390/jcm13154304.
5
Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting.机械通气作为新冠病毒疾病住院费用的主要驱动因素:一项德国环境下的成本研究
Health Econ Rev. 2024 Jan 16;14(1):4. doi: 10.1186/s13561-023-00476-1.
6
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study.英格兰 COVID-19 成年患者的医疗资源利用情况以及住院和初级保健的费用:一项基于人群的队列研究。
BMJ Open. 2023 Dec 28;13(12):e075495. doi: 10.1136/bmjopen-2023-075495.
7
What Makes a Hospital Excellent? A Qualitative Study on the Organization and Management of Five Leading Public Hospitals in China.是什么造就了卓越的医院?对中国五家顶尖公立医院组织与管理的定性研究。
Risk Manag Healthc Policy. 2023 Sep 18;16:1915-1927. doi: 10.2147/RMHP.S424711. eCollection 2023.
8
Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain.2020 年西班牙无症状 COVID-19 住院患者的患病率和费用。
Front Public Health. 2023 Aug 1;11:1229561. doi: 10.3389/fpubh.2023.1229561. eCollection 2023.
9
A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy.意大利医院层面上 SARS-CoV-2 大流行的经济影响的重复横断面分析。
Sci Rep. 2023 Jul 31;13(1):12386. doi: 10.1038/s41598-023-39592-7.
10
Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions.2020-2021 年中国深圳 COVID-19 住院患者的治疗费用评估:事实与建议。
Front Public Health. 2023 May 4;11:1066694. doi: 10.3389/fpubh.2023.1066694. eCollection 2023.
Health Econ Rev. 2021 Oct 8;11(1):39. doi: 10.1186/s13561-021-00338-8.
4
Inpatient Hospital Costs for COVID-19 Patients in the United States.美国 COVID-19 患者的住院费用。
Adv Ther. 2021 Nov;38(11):5557-5595. doi: 10.1007/s12325-021-01887-4. Epub 2021 Oct 5.
5
Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis.中重度 COVID-19 呼吸道疾病的治疗:成本效用分析。
Sci Rep. 2021 Sep 7;11(1):17787. doi: 10.1038/s41598-021-97259-7.
6
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review.当前用于治疗 COVID-19 的研究药物的疗效:范围综述。
Ann Med. 2021 Dec;53(1):318-334. doi: 10.1080/07853890.2021.1875500.
7
A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.用于美国住院患者的 COVID-19 治疗的成本效益框架。
Adv Ther. 2021 Apr;38(4):1811-1831. doi: 10.1007/s12325-021-01654-5. Epub 2021 Feb 27.
8
Prediction of the COVID-19 outbreak in China based on a new stochastic dynamic model.基于新的随机动力学模型预测中国的 COVID-19 疫情。
Sci Rep. 2020 Dec 9;10(1):21522. doi: 10.1038/s41598-020-76630-0.
9
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.南非 COVID-19 疫情防控公共卫生策略的成本效益:微观模拟建模研究。
Lancet Glob Health. 2021 Feb;9(2):e120-e129. doi: 10.1016/S2214-109X(20)30452-6. Epub 2020 Nov 11.
10
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.抗病毒治疗在大流行和呼吸道疾病(包括 COVID-19)暴发中的成本效益:已发表经济评估的系统综述。
Value Health. 2020 Nov;23(11):1409-1422. doi: 10.1016/j.jval.2020.07.002. Epub 2020 Sep 6.